Ibex Investors LLC lessened its stake in USANA Health Sciences, Inc. (NYSE:USNA) by 49.4% in the 3rd quarter, Holdings Channel reports. The firm owned 1,739 shares of the company’s stock after selling 1,699 shares during the quarter. Ibex Investors LLC’s holdings in USANA Health Sciences were worth $210,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently bought and sold shares of the company. NEXT Financial Group Inc purchased a new position in USANA Health Sciences in the 3rd quarter worth about $121,000. Harvest Fund Management Co. Ltd raised its position in USANA Health Sciences by 418.6% in the 3rd quarter. Harvest Fund Management Co. Ltd now owns 1,224 shares of the company’s stock worth $148,000 after buying an additional 988 shares during the last quarter. Amalgamated Bank purchased a new position in USANA Health Sciences in the 2nd quarter worth about $223,000. Nomura Holdings Inc. purchased a new position in USANA Health Sciences in the 2nd quarter worth about $250,000. Finally, Janus Henderson Group PLC purchased a new position in USANA Health Sciences in the 3rd quarter worth about $258,000. 54.53% of the stock is owned by hedge funds and other institutional investors.

A number of brokerages have weighed in on USNA. ValuEngine lowered USANA Health Sciences from a “buy” rating to a “hold” rating in a research report on Thursday, November 8th. Sidoti raised USANA Health Sciences from a “neutral” rating to a “buy” rating in a research report on Thursday, October 25th. Finally, Pivotal Research raised USANA Health Sciences from a “hold” rating to a “buy” rating and set a $135.00 target price for the company in a research report on Wednesday, October 24th.

In other USANA Health Sciences news, insider Walter Noot sold 363 shares of the business’s stock in a transaction dated Thursday, November 8th. The stock was sold at an average price of $119.50, for a total transaction of $43,378.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Myron W. Wentz purchased 6,697 shares of the business’s stock in a transaction on Friday, December 7th. The shares were purchased at an average price of $70.46 per share, with a total value of $471,870.62. The disclosure for this purchase can be found here. Over the last 90 days, insiders have acquired 19,117 shares of company stock valued at $1,349,965 and have sold 183,321 shares valued at $20,929,948. Insiders own 53.20% of the company’s stock.

USANA Health Sciences stock opened at $120.74 on Friday. The stock has a market cap of $2.86 billion, a price-to-earnings ratio of 29.74 and a beta of 0.79. USANA Health Sciences, Inc. has a 52-week low of $69.55 and a 52-week high of $137.95.

USANA Health Sciences (NYSE:USNA) last released its quarterly earnings results on Tuesday, October 23rd. The company reported $1.24 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.10 by $0.14. The business had revenue of $296.80 million during the quarter, compared to the consensus estimate of $289.54 million. USANA Health Sciences had a return on equity of 29.67% and a net margin of 7.57%. The business’s quarterly revenue was up 13.4% compared to the same quarter last year. During the same period in the previous year, the company posted $1.03 EPS.

USANA Health Sciences announced that its board has initiated a share buyback plan on Tuesday, October 23rd that permits the company to buyback $150.00 million in shares. This buyback authorization permits the company to repurchase up to 5.9% of its stock through open market purchases. Stock buyback plans are often an indication that the company’s leadership believes its stock is undervalued.

ILLEGAL ACTIVITY NOTICE: “USANA Health Sciences, Inc. (USNA) Stake Lessened by Ibex Investors LLC” was posted by Watch List News and is owned by of Watch List News. If you are reading this news story on another domain, it was stolen and republished in violation of U.S. & international trademark & copyright law. The original version of this news story can be read at https://www.watchlistnews.com/usana-health-sciences-inc-usna-stake-lessened-by-ibex-investors-llc/2667770.html.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition.

Further Reading: What are defining characteristics of a correction?

Want to see what other hedge funds are holding USNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for USANA Health Sciences, Inc. (NYSE:USNA).

Institutional Ownership by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.